Doximity, Inc. (NYSE:DOCS) Stock Has Average Price Target of $30.73

Doximity, Inc. (NYSE:DOCS) has received a consensus recommendation of “Hold” from the twenty-five research firms that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $30.73.

A number of equities research analysts have issued reports on the company. Canaccord Genuity Group set a $36.00 target price on Doximity in a research report on Friday, August 7th. Evercore set a $35.00 price target on Doximity in a report on Tuesday, September 29th. Weiss Ratings upgraded shares of Doximity from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, October 6th. Truist Financial boosted their target price on shares of Doximity from $19.00 to $24.00 and gave the stock a “hold” rating in a research report on Thursday, August 13th. Finally, JPMorgan Chase & Co. upped their target price on shares of Doximity from $26.00 to $31.00 and gave the company a “neutral” rating in a research note on Friday, August 7th.

Doximity News Roundup

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Fiscal Q2 revenue was $174.5 million, ahead of the $170.8 million FactSet estimate, while EPS of $0.36 topped Zacks’ $0.34 consensus. Doximity also forecast Q3 revenue of $195–$196 million and FY2027 revenue of $678–$683 million, both above analyst expectations. Fiscal 2027 second-quarter results
• Positive Sentiment: Management cited record engagement, a 51% adjusted EBITDA margin, and adoption of its AI suite by more than 190 health systems. The company is expanding its offering with UpToDate and DoseCheck. Company results and management commentary
• Neutral Sentiment: Despite the earnings beat, EPS was down from $0.45 a year earlier. A report noted that DOCS stock fell after the sales beat, suggesting the positive results and guidance did not fully satisfy investors’ expectations. Doximity sales beat estimates but stock drops
• Negative Sentiment: Multiple law firms highlighted a pending securities class action and a November 16 lead-plaintiff deadline. The lawsuit alleges Doximity misrepresented the Newsfeed product’s contribution to revenue growth and its competitive position; these claims have not been established in court. The litigation adds uncertainty. Securities class action notice

Insiders Place Their Bets

In other news, Director Watkin Phoebe L. Yang sold 1,290 shares of the business’s stock in a transaction that occurred on Wednesday, September 30th. The stock was sold at an average price of $26.71, for a total transaction of $34,455.90. Following the sale, the director directly owned 24,744 shares in the company, valued at approximately $660,912.24. The trade was a 4.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Siddharth Sitaram sold 2,613 shares of the stock in a transaction on Wednesday, October 14th. The shares were sold at an average price of $30.68, for a total transaction of $80,166.84. Following the completion of the transaction, the chief accounting officer owned 101,432 shares of the company’s stock, valued at approximately $3,111,933.76. This represents a 2.51% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 13,750 shares of company stock worth $386,310 in the last ninety days. Insiders own 31.80% of the company’s stock.

Institutional Investors Weigh In On Doximity

A number of institutional investors have recently added to or reduced their stakes in DOCS. Carmignac Gestion increased its position in shares of Doximity by 127.8% during the 1st quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after purchasing an additional 2,418,971 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Doximity by 24.7% during the 2nd quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after purchasing an additional 621,464 shares during the last quarter. Quantinno Capital Management LP boosted its position in Doximity by 420.5% in the first quarter. Quantinno Capital Management LP now owns 140,345 shares of the company’s stock valued at $3,270,000 after buying an additional 113,380 shares in the last quarter. Royal Bank of Canada boosted its position in Doximity by 28.4% in the first quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock valued at $4,806,000 after buying an additional 45,618 shares in the last quarter. Finally, Assenagon Asset Management S.A. acquired a new position in Doximity in the third quarter valued at about $28,858,000. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Trading Down 3.9%

Shares of Doximity stock opened at $33.32 on Friday. The stock has a 50-day moving average price of $28.95 and a 200 day moving average price of $25.55. The company has a market cap of $5.94 billion, a P/E ratio of 39.20, a P/E/G ratio of 27.12 and a beta of 1.29. Doximity has a 1 year low of $17.15 and a 1 year high of $64.55.

Doximity (NYSE:DOCS) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.13. The business had revenue of $156.62 million during the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%. Doximity’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.36 earnings per share. On average, equities analysts forecast that Doximity will post 0.74 earnings per share for the current fiscal year.

Doximity Company Profile

Doximity, Inc operates a digital platform designed for medical professionals in the United States. Its network connects physicians, nurse practitioners, physician assistants, pharmacists and other healthcare professionals, providing tools for professional communication, collaboration and career development.

The company offers services including secure messaging, telehealth, digital faxing, physician scheduling and professional networking. Doximity also provides medical news and educational content, as well as recruiting and job-search resources for healthcare professionals.

Doximity generates additional revenue through digital marketing and engagement solutions for pharmaceutical companies, healthcare organizations and health systems.